Obsidian Therapeutics, Inc.
OBX
$18.68
-$0.05-0.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -25.86M | -19.63M | -26.90M | ||
| Total Depreciation and Amortization | 295.00K | 340.00K | 374.00K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 1.41M | 1.14M | 1.98M | ||
| Change in Net Operating Assets | -1.11M | -3.86M | 3.05M | ||
| Cash from Operations | -25.27M | -22.01M | -21.50M | ||
| Capital Expenditure | -- | -- | -1.00K | ||
| Sale of Property, Plant, and Equipment | 19.00K | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 16.00M | 8.00M | 17.25M | ||
| Cash from Investing | 16.02M | 8.00M | 17.25M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 796.00K | 47.00K | 12.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 796.00K | 47.00K | 12.00K | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -8.46M | -13.97M | -4.24M | ||